Now You Can Get Your Flu Vaccine at Home
The nasal spray vaccine FluMist can now be ordered online and shipped to your door.
RFK Jr. Is Supporting mRNA Research—Just Not for Vaccines
HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.
This Might Be the Most Massive Black Hole Ever Discovered
New measurements of the galaxy at the heart of the “Cosmic Horseshoe” indicate that it could house the most massive object ever seen in the universe.
Central American Beaches Are Being Overrun With Local and Foreign Plastic
A study of plastic bottles washed up on the Pacific coast of Latin America has identified a double problem—a mass of local waste combined with long-traveling bottles from Asia.
An AI Model for the Brain Is Coming to the ICU
The Cleveland Clinic and startup Piramidal are developing an AI model trained on brain wave data to monitor intensive care patients.
The Black Market for Fake Science Is Growing Faster Than Legitimate Research, Study Warns
A small but growing number of academics are improperly taking credit for articles, citations, and authorships, allowing them to appear prestigious without having conducted their own research.
This New Pyramid-Like Shape Always Lands With the Same Side Up
A tetrahedron is the simplest Platonic solid. Mathematicians have now made one that’s stable only on one side, confirming a decades-old conjecture.
Private Companies Are Now Gathering Weather Data for NOAA
WindBorne Systems is one of several companies launching balloons, drones, buoys, and other devices to provide critical data to the beleaguered agency’s National Weather Service, but they can’t fill all the gaps.
Why the US Is Racing to Build a Nuclear Reactor on the Moon
NASA has set a 2030 deadline to build a 100-kilowatt nuclear reactor on the moon. It’s an ambitious but potentially achievable goal that could transform space exploration, experts tell WIRED.
Eli Lilly’s Obesity Pill Shows Promising Weight Loss in New Results
In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.